Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04860856
Other study ID # OS19011 IRB 2019-0366
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date August 17, 2019
Est. completion date February 7, 2023

Study information

Verified date February 2023
Source University of Cincinnati
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of an intra-operative, post-fixation fracture hematoma block compared to saline control on postoperative pain control in patients with acute femoral shaft fractures. Our primary outcome measure is visual analog scale (VAS) pain scores which are recorded at regular intervals.


Description:

This blinded, randomized control trial is being performed at the University of Cincinnati Medical Center. Patients will be randomly assigned to one of two treatment groups: Group One will be comprised of patients treated with fracture site injection containing 20 mL of 0.5% ropivacaine with an 18-gauge needle (150 mm length), Group Two will be comprised of patients treated with fracture site injection containing 20ml of normal saline. The injection will be administered by the orthopaedic trauma team after the insertion of the final intramedullary implant and skin closure prior to final surgical dressing application. The injection will be performed in a standard fashion with aspiration of hematoma followed by the injection. All postoperative management will be per standard of care. The size of the hematoma will have no effect on the procedure. When a hematoma block is utilized in the care of orthopaedic trauma patients, its aim is to infiltrate the anesthetic to the fracture edges and injured soft tissue to allow for pain control and fracture manipulation without additional sedation. Aspiration of the hematoma tells the clinician that the tip of the needle is near the fracture site and not in a neurovascular structure. The maximal single dose of ropivacaine without vasoconstrictor is 2-3 mg/kg.9 0.5% ropivacaine has 5 mg/mL of ropivacaine. 20 mL of 0.5% ropivacaine has 100 mg of ropivacaine. 100 mg of ropivacaine can be toxic to a patient less than 33-50 kg or 73-110 lb. If a patient weighs less than 110 lb, the ropivacaine dose will be scaled down below 2 mg/kg. Regional anesthesia including nerve blocks is not routinely used in the setting of traumatic femoral shaft fractures. A nerve block would compromise the patient's neurologic examination in the immediate postoperative period. Randomization will be performed via Microsoft Excel to generate random numbers. Allocation will be concealed and revealed to the surgical team in the hour prior to the procedure. The patients and the nursing staff who assess postoperative pain will be blinded to the treatment allocation. An a priori power analysis was performed to determine the sample size for the primary outcome measure. Prior literature has indicated that a difference of 1.3 on a VAS is clinically significant.5 Therefore, it was determined that a total of 44 patients were necessary per group to detect a 1.5-point difference on the VAS (power = 80%, p = 0.05).


Recruitment information / eligibility

Status Completed
Enrollment 88
Est. completion date February 7, 2023
Est. primary completion date February 7, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Trauma patient at the University of Cincinnati Medical Center - Skeletally mature patients - Have an isolated, closed, acute traumatic femoral shaft fracture to be treated with a closed reduction and reamed intramedullary rod fixation Exclusion Criteria: - Unable to provide informed consent - Member of a vulnerable patient population - Have additional injuries - Have a history of prior existing narcotic use or chronic pain management issues on presentation

Study Design


Intervention

Drug:
0.5% ropivacaine
The maximal single dose of ropivacaine without vasoconstrictor is 2-3 mg/kg.9 0.5% ropivacaine has 5 mg/mL of ropivacaine. 20 mL of 0.5% ropivacaine has 100 mg of ropivacaine. 100 mg of ropivacaine can be toxic to a patient less than 33-50 kg or 73-110 lb. If a patient weighs less than 110 lb, the ropivacaine dose will be scaled down below 2 mg/kg.
Normal Saline
20ml of normal saline

Locations

Country Name City State
United States University of Cincinnati College of Medicine Cincinnati Ohio

Sponsors (1)

Lead Sponsor Collaborator
University of Cincinnati

Country where clinical trial is conducted

United States, 

References & Publications (8)

Alioto RJ, Furia JP, Marquardt JD. Hematoma block for ankle fractures: a safe and efficacious technique for manipulations. J Orthop Trauma. 1995 Apr;9(2):113-6. doi: 10.1097/00005131-199504000-00004. — View Citation

Bear DM, Friel NA, Lupo CL, Pitetti R, Ward WT. Hematoma block versus sedation for the reduction of distal radius fractures in children. J Hand Surg Am. 2015 Jan;40(1):57-61. doi: 10.1016/j.jhsa.2014.08.039. Epub 2014 Oct 11. — View Citation

Case RD. Haematoma block--a safe method of reducing Colles' fractures. Injury. 1985 Jul;16(7):469-70. doi: 10.1016/0020-1383(85)90168-8. — View Citation

Dimopoulou I, Anagnostou TL, Prassinos NN, Savvas I, Patsikas M. Effect of intrafragmentary bupivacaine (haematoma block) on analgesic requirements in dogs undergoing fracture repair. Vet Anaesth Analg. 2017 Sep;44(5):1189-1197. doi: 10.1016/j.vaa.2017.01.005. Epub 2017 Mar 6. — View Citation

Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001 Dec;38(6):633-8. doi: 10.1067/mem.2001.118863. — View Citation

Herrera JA, Wall EJ, Foad SL. Hematoma block reduces narcotic pain medication after femoral elastic nailing in children. J Pediatr Orthop. 2004 May-Jun;24(3):254-6. doi: 10.1097/00004694-200405000-00003. — View Citation

Johnson PQ, Noffsinger MA. Hematoma block of distal forearm fractures. Is it safe? Orthop Rev. 1991 Nov;20(11):977-9. — View Citation

Koehler D, Marsh JL, Karam M, Fruehling C, Willey M. Efficacy of Surgical-Site, Multimodal Drug Injection Following Operative Management of Femoral Fractures: A Randomized Controlled Trial. J Bone Joint Surg Am. 2017 Mar 15;99(6):512-519. doi: 10.2106/JBJS.16.00733. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in postoperative pain at 72 hours Postoperative pain will be assessed using a visual analog scale Measured at 0, 8, 16, 24, 36, 48, and 72 hours postoperatively
Secondary Narcotic usage Oral morphine equivalents will be recorded Narcotic usage will be assessed through 72 hours postoperatively
See also
  Status Clinical Trial Phase
Completed NCT03231787 - Clinical Trial in Antiaggregated Patients With Proximal Femur Fracture Evaluating a Strategy to Shorten Time Until Surgery N/A
Completed NCT00888160 - Timing of Orthopaedic Surgery in the Multiply-injured Patient: Development of a Protocol for Early Appropriate Care
Recruiting NCT05613257 - Distal Targeter vs Free-hand N/A
Withdrawn NCT00240396 - Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture N/A
Recruiting NCT01969279 - Radiographic Influences of Bisphosphonate Treatment on Femur N/A
Terminated NCT03160508 - Trochanter Fixation Nail Advanced (TFNA) Weight Bearing
Completed NCT04127045 - ProspEctive Cohort Study on Multidisciplinary Approach to Femur FRactures' manAgement in Over 65 Population
Recruiting NCT03868280 - The FLiP Study, a Pilot Cluster Randomized Trial N/A
Completed NCT00725894 - Pediatric Locking Nail for the Treatment of Femoral Fractures in Children N/A
Recruiting NCT04657510 - Femoral frACturEs and COVID-19.
Completed NCT05225753 - Post-operative Anemia in Lateral Fractures of the Femur.
Active, not recruiting NCT03775408 - FAST: Clinical Feasibility
Completed NCT02793947 - Efficacy of Peri-Incisional Multimodal Drug Injection Following Operative Management of Femur Fractures Phase 4
Completed NCT00916136 - Skeletal Versus Cutaneous Traction For Treatment of Femur Fractures N/A
Completed NCT05183308 - Combined Drug Therapy in Lateral Fragility Fractures of the Femur
Not yet recruiting NCT00616044 - Continuous Spinal Anesthesia Versus Combined Spinal Epidural Block N/A
Terminated NCT01484405 - Anterolateral Versus Posterior Approach for Total Hip Arthroplasty After Displaced Femoral Neck Fracture N/A
Completed NCT00943332 - Pediatric Femur Research Project
Not yet recruiting NCT00686023 - Comparing Surgical Techniques for CRIF of Pertrochanteric Fractures N/A
Completed NCT01293916 - Spica Casting in Pediatric Femur Fractures: Study of Single Leg Versus Double Leg Spica Casts N/A